SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-005016
Filing Date
2022-02-02
Accepted
2022-02-02 14:46:34
Documents
13
Period of Report
2022-02-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT FILING ea154850-8k_bimiint.htm   iXBRL 8-K 25866
2 PRESS RELEASE DATED FEBRUARY 2, 2022 ea154850ex99-1_bimiint.htm EX-99.1 4856
  Complete submission text file 0001213900-22-005016.txt   207730

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bimi-20220202.xsd EX-101.SCH 3060
4 XBRL LABEL FILE bimi-20220202_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE bimi-20220202_pre.xml EX-101.PRE 22613
7 EXTRACTED XBRL INSTANCE DOCUMENT ea154850-8k_bimiint_htm.xml XML 3757
Mailing Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100
Business Address NO. 10, HUASHENG ROAD, FLOOR 21 YUZHONG DISTRICT CHONGQING, P.R. F4 404100 (8604) 1182209211
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 22583029
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries